Yahoo's (ZHCLF) Company Profile:
Zenith Capital Corp. (ZHCLF)
Other OTC - Other OTC Delayed Price. Currency in USD
0.5300+0.4591 (+647.53%)
At close: October 19 3:19PM EDT
"Company Profile
Zenith Capital Corp., a biotechnology investment company, develops bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. Its lead compound ZEN-3694 which is in phase II clinical trials for the treatment of metastatic castration resistant prostate cancer and in a phase 1b/2 clinical trial for triple negative breast cancer. The company was incorporated in 2013 and is based in Calgary, Canada."
Koo